Get the Stockscreener App
0.042
2.44%
0.001
Pre-market:
.04
-0.002
-4.76%
Petros Pharmaceuticals Inc stock is traded at $0.042, with a volume of 4.31M.
It is up +2.44% in the last 24 hours and down -42.47% over the past month.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
See More
Previous Close:
$0.041
Open:
$0.0405
24h Volume:
4.31M
Relative Volume:
0.13
Market Cap:
$1.38M
Revenue:
$4.02M
Net Income/Loss:
$-4.73M
P/E Ratio:
-0.00998
EPS:
-4.21
Net Cash Flow:
$-5.85M
1W Performance:
-8.70%
1M Performance:
-42.47%
6M Performance:
-89.94%
1Y Performance:
-93.73%
1-Day Range:
$0.0364
$0.0424
1-Week Range:
$0.0364
$0.046
52-Week Range:
$0.0364
$0.7664
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Name
Petros Pharmaceuticals Inc
Sector
Phone
973-242-0005
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Compare PTPI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.042 | 1.38M | 4.02M | -4.73M | -5.85M | -4.21 |
|
ZTS
Zoetis Inc
|
146.85 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.19 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.31 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.25 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Petros Pharmaceuticals Inc Stock (PTPI) Latest News
Petros Pharmaceuticals stock hits 52-week low at $0.04 By Investing.com - Investing.com South Africa
Ratio Analysis: Unpacking Petros Pharmaceuticals Inc (PTPI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Petros Pharmaceuticals stock hits 52-week low at $0.04 - Investing.com
Petros Pharmaceuticals faces delisting, stockholders approve equity changes - Investing.com Australia
Petros Pharmaceuticals faces delisting, stockholders approve equity changes By Investing.com - Investing.com Canada
Petros Pharmaceuticals Approves Key Amendments to Incorporation - TipRanks
Petros Pharmaceuticals appoints new auditor for 2025 By Investing.com - Investing.com South Africa
Petros Pharmaceuticals appoints new auditor for 2025 - Investing.com
PTPI stock plunges to 52-week low of $0.05 amid market challenges By Investing.com - Investing.com South Africa
PTPI stock plunges to 52-week low of $0.05 amid market challenges - Investing.com India
Petros Pharmaceuticals modifies terms with investors - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Petros Pharmaceuticals, Inc. SEC 10-K Report - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Petros Pharmaceuticals enters collaboration with big data, analytics firm - MSN
Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
3 Penny Stocks to Watch Now, 3/27/25 - TipRanks
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket - Benzinga
"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, - openPR
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? - Yahoo Finance
Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Apellis Pharmaceuticals, Inc. (APLS) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Petro-Victory Energy Corp Announces Extension to US $1,700,000 Note - Yahoo Finance
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst? - Yahoo Finance
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme - Yahoo Finance
Innovations In Medical Technology And Materials Drive Advancements In Erectile Dysfunction Treatments: Key ... - WhaTech
EXCLUSIVE: MIRA Pharmaceuticals Signs To Acquire SKNY Pharmaceuticals, Expand Pipeline Into Weight Loss And Smoking Cessation Drug - Yahoo Finance
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Petros Pharmaceuticals enhances Rx-to-OTC switch technology By Investing.com - Investing.com South Africa
Petros Pharmaceuticals enhances Rx-to-OTC switch technology - Investing.com
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - ACCESS Newswire
Petros Pharmaceuticals Targets $38B Self-Care Market with Game-Changing AI Drug Platform - StockTitan
PTPI stock plunges to 52-week low of $0.07 amid market challenges By Investing.com - Investing.com South Africa
PTPI stock plunges to 52-week low of $0.07 amid market challenges - Investing.com Australia
Nvidia GTC 2025: What to expect from Nvidia's biggest event of the year - Yahoo Finance
PTPI’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now - Yahoo Finance
Petro-Victory Energy and BlueOak Investments to acquire Capixaba Energia - Yahoo Finance
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - Yahoo Finance
Entrada Therapeutics, Inc. Just Beat EPS By 55%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Internationally Published, Head-to-Head Data From India of Petros Pharmaceuticals' STENDRA(R) (Avanafil) Tablets Reported Improvement in Erectile Function Compared to Sildenafil and Baseline After 12 Weeks of Therapy - ACCESS Newswire
Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More - Yahoo Finance
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022 - ACCESS Newswire
New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy - ACCESS Newswire
Petros Pharmaceuticals Inc Stock (PTPI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):